SOURCE: Cypress Bioscience, Inc.

May 06, 2008 06:30 ET

Cypress Bioscience, Inc. to Present at The Neurotech Industry Investing & Partnering Conference

SAN DIEGO, CA--(Marketwire - May 6, 2008) - Cypress Bioscience, Inc. (NASDAQ: CYPB) today announced that Dr. Srinivas G. Rao, its Chief Scientific Officer, will be participating in a panel presentation on May 8th at 2:30 pm Eastern Time at The Neurotech Industry Investing & Partnering Conference being held at the Westin Copley Place in Boston, MA. This conference will focus on advances in drugs, devices and diagnostics for the brain and nervous system.

The meeting will feature presentations from over 50 speakers about next generation treatments for Alzheimer's, addiction, anxiety, depression, epilepsy, insomnia, multiple sclerosis, obesity, pain, Parkinson's, schizophrenia, stroke and other brain-related illnesses.

About Cypress Bioscience, Inc.

Cypress Bioscience is committed to developing and commercializing pharmaceutical products and personalized medicine laboratory services that allow physicians to serve unmet medical needs. Cypress' strategy involves evaluating various other potential strategic transactions, including the potential acquisition of products, product candidates, technologies and companies, and other alternatives.

For more information about Cypress, please visit the Company's website at www.cypressbio.com.

Contact Information

  • For additional information please contact
    For Cypress Bioscience:
    Michael Hufford
    VP Corporate Development
    Mary Gieson
    Investor Relations
    (858) 452-2323
    Email Contact